A structural model of toxic amyloid oligomers involved in type 2 diabetes

Read full text
Authors: Shivani T. Shivani, Brynn E. LeMasters, Thirupathi Ravula, Harrison J. Esterly, Nikhil Maroli, Kacie L. Rich, Caitlyn R. Fields, Sidney S. Dicke, Owen A. Warmuth, Donald S. Stapleton, Mark P. Keller, Alan Attie
+4 more Alexei A. Kananenka, Katherine A. Henzler‐Wildman, Chad M. Rienstra, Martin T. Zanni
Cited by: 6
References: 47

Abstract

Amyloid oligomers of the human islet amyloid polypeptide (hIAPP) are a likely cytotoxic species driving β-cell death in type 2 diabetes, but their transient nature has precluded atomic-level structural characterization. We obtained a high-resolution structure of a physiologically relevant hIAPP oligomer. Using 2D IR spectroscopy, we identified three substitutions that slowed aggregation sufficiently for comprehensive 2D/3D NMR analysis while retaining the key wild-type structural features and cytotoxicity. The structural model reveals a dimeric assembly with N-terminal helices and a kink that facilitates an intermolecular β-sheet. The β-sheet spans the famous FGAILS portion of the sequence, helping to explain species-specific diabetes susceptibility and the origin of early-onset familial mutations. The integrated 2D IR/NMR strategy provides a unique approach to obtaining high-resolution structures of amyloid oligomers.

Fields of Study & Subjects

Alzheimer's disease research and treatments Protein Structure and Dynamics Amyloidosis: Diagnosis Treatment Outcomes

Publication details

Journal / source
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences
Volume
123
Issue
5
Pages
e2528103123–e2528103123
Publication date
26 January 2026
Language
EN